
News|Articles|July 1, 2008
Drug Watch: Agents in late-stage development for the treatment of adult and juvenile rheumatoid arthritis (July 2008) (PDF)
Drugs in development for the treatment of adult and juvenile rheumatoid arthritis
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Centanafadine hits primary and key secondary endpoints in ADHD phase 3b trial
3
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
4
New study confirms benefits of GLP-1 drugs in patients with PAD
5
































